Prospective trial of artificial intelligence three-dimensional reconstruction technology in total hip arthroplasty

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100053886

Enrollment

Unknown

Registered

2021-12-02

Start date

2021-12-07

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Necrosis of the femoral head, femoral neck fracture, congenital dysplasia of the hip

Interventions

Control group:traditional surgical methods

Experimental group:AI 3D reconstruction assistance technology

Eligibility

Sex/Gender

All

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 40-70 years; 2. Diagnosed as Osteonecrosis of the Femoral Head (ONFH) or Congenital Dysplasia of the Hip (DDH); 3. The unilateral hip joint experimental group (using AI three-dimensional reconstruction assisted technology) has disease, and the contralateral side is normal; those treated with THA; 4. The patient's hospitalized case data and postoperative follow-up data are complete and the mental state, cognitive function and compliance are all good.

Exclusion criteria

Exclusion criteria: 1. Associated with other fractures; 2. Combined with more serious medical underlying diseases affecting the postoperative recovery of patients; 3. Those with incomplete follow-up data or the follow-up time less than 3 months.

Design outcomes

Primary

Measure	Time frame
Intraoperative time-consuming;Perioperative blood loss;Prosthesis matching;Harris score;	—

Countries

China

Contacts

Public ContactLi Junjie

Fujian Provincial Hospital

825874156@qq.com+86 18359181965

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026